secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001156039-24-000093
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health reaffirms FY2024 net income >$34.05, adjusted >$37.20 per share
-------------------------------------------------------------------------------

- Net income guidance for FY2024 greater than $34.05 per diluted share including approximately $3.15 per share of net unfavorable items.
- Adjusted net income guidance greater than $37.20 per diluted share, excluding the unfavorable items.
- Guidance does not include any adjustment items beyond those reported in Q1 2024 earnings release.
- Company officers reaffirming guidance during investor meetings over the next several weeks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603924000093/0001156039-24-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603924000093/item701guidancejune2024.htm
  HTML page:      https://secwatch.observer/filing/0001156039-24-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer